Zobrazeno 1 - 10
of 26
pro vyhledávání: '"V, Trastek"'
Autor:
T. Feeney, O. O’Muire, J. J. Gilmartin, P. Manning, H. Sinclair, L. Clancy, F. O’Connell, D. R. Springall, J. M. Polak, V. E. Thomas, R. W. Fuller, N. B. Pride, R. A. Lyons, C. Leonard, J. Faul, V. J. Tormey, L. W. Poulter, C. M. Burke, S. Pathmakanthan, M. C. Barry, J. H. Wang, C. J. Kelly, P. E. Burke, S. J. Sheehan, H. P. Redmond, D. Bouchier-Hayes, H. Abdih, R. W. G. Watson, P. Burke, J. J. Egan, L. Barber, J. Lomax, A. Fox, J. Craske, N. Yonan, A. N. Rahman, A. K. Deiraniya, K. B. Carroll, A. Turner, A. A. Woodcock, K. McNeill, B. Bookless, K. Gould, P. Corris, T. Higgenbottam, A. Webb, A. Woodcock, K. McManus, D. Miller, M. Allen, D. Ilstrup, C. Deschamps, V. Trastek, P. Pairolero, T. P. Cotter, C. Vaughan, W. P. Kealy, P. F. Duggan, A. Curtain, C. P. Bredin, A. Waite, C. P. Maguire, J. Ryan, D. O’Neill, D. Coakley, J. B. Walsh, I. Kilgallen, S. O’Neill, M. Ryan, C. M. O’Connor, T. McDonnell, R. C. Lowry, J. B. Buick, T. R. A. Magee, D. O’Riordan, J. Hayes, C. O’Connor, M. X. FitzGerald, C. Cosgrave, C. Costello, P. C. Deegan, W. T. McNicholas, A. M. Nugent, J. Lyons, I. Gleadhill, J. MacMahon, E. C. Stevenson, L. G. Heaney, M. D. Shields, I. S. Cadden, R. Taylor, M. Ennis, S. A. Kharitonov, J. O’Connor, W. A. Owens, H. O’Kane, J. Cleland, D. J. Gladstone, M. Sarsam, A. N. J. Graham, V. Anikin, J. A. McGuigan, R. C. Curry, G. Varghese, P. Keelan, R. Rutherford, D. O’Keeffe, P. McCarthy, H. Moore, E. Balbernie, R. Coakley, M. Keane, R. Costello, P. Byrne, D. McKeogh, P. McLoughlin, G. Finlay, D. Concannon, D. McKeown, P. Kelly, W. A. Tanner, D. J. Bouchier-Hayes, M. Arumugasamy, K. Yacoub, G. O’Leary, K. Stokes, J. Geraghty, H. Osborne, R. O’Dwyer, R. Gilliland, S. M. Saleem, T. Aherne, C. K. Power, C. H. Burke, A. Byrne, J. F. A. Murphy, R. Sharkey, E. Mulloy, K. Sharkey, M. Long, M. A. Birchall, A. Moorat, J. Henderson, L. Jacques, P. Cahill, C. Condron, D. Royston, J. Murphy, S. O. Neill
Publikováno v:
Irish Journal of Medical Science. 164:159-174
Autor:
S A, Nicholson, N T, Okby, M A, Khan, J A, Welsh, M G, McMenamin, W D, Travis, J R, Jett, H D, Tazelaar, V, Trastek, P C, Pairolero, P G, Corn, J G, Herman, L A, Liotta, N E, Caporaso, C C, Harris
Publikováno v:
Cancer research. 61(14)
Overexpression of E2F-1 induces apoptosis by both a p14ARF-p53- and a p73-mediated pathway. p14ARF is the alternate tumor suppressor product of the INK4a/ARF locus that is inactivated frequently in lung carcinogenesis. Because p14ARF stabilizes p53,
Autor:
A J, Marrogi, W D, Travis, J A, Welsh, M A, Khan, H, Rahim, H, Tazelaar, P, Pairolero, V, Trastek, J, Jett, N E, Caporaso, L A, Liotta, C C, Harris
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(12)
We have investigated the hypothesis that nitric oxide synthase (NOS2), cyclooxygenase-2 (COX2), and vascular endothelial growth factor (VEGF) protein levels individually demonstrate a direct correlation with microvessel density (MVD) and clinical out
Autor:
L, Burke, M A, Khan, A N, Freedman, A, Gemma, M, Rusin, D G, Guinee, W P, Bennett, N E, Caporaso, M V, Fleming, W D, Travis, T V, Colby, V, Trastek, P C, Pairolero, H D, Tazelaar, D E, Midthun, L A, Liotta, C C, Harris
Publikováno v:
Cancer research. 58(12)
The fragile histidine triad (FHIT) gene at chromosome 3p14.2 is a candidate tumor suppressor gene linked to cancers of the lung, breast, colon, pancreas, and head and neck. Reports of frequent allelic deletion and abnormal transcripts in primary lung
Autor:
W P, Bennett, W S, el-Deiry, W L, Rush, D G, Guinee, A N, Freedman, N E, Caporaso, J A, Welsh, R T, Jones, A, Borkowski, W D, Travis, M V, Fleming, V, Trastek, P C, Pairolero, H D, Tazelaar, D, Midthun, J R, Jett, L A, Liotta, C C, Harris
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(6)
p21waf1/cip1 encodes a cyclin-dependent kinase inhibitor that is transcriptionally activated by the p53 tumor suppressor gene, transforming growth factor beta 1 (TGF-beta 1), AP2, and other pathways. Because p21waf1/cip1, p53, and TGF-beta 1 all regu
Autor:
L C, Harty, D G, Guinee, W D, Travis, W P, Bennett, J, Jett, T V, Colby, H, Tazelaar, V, Trastek, P, Pairolero, L A, Liotta, C C, Harris, N E, Caporaso
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 5(12)
p53 mutations are frequent in malignant lung tumors. Of 88 surgically treated lung cancers from cigarette smokers previously evaluated for p53 mutations, 45 tumors (51.1%) had mutations in exons 5-8 (D. G. Guinee, Jr. et al., Carcinogenesis (Lond.),
Autor:
V. Trastek, David E. Midthun, D.G. Guinee, William D. Travis, I.A. Liotta, Akihiko Gemma, W.P. Bennett, Neil E. Caporaso, A.N Freedman, M.A. Khan, Marian V. Fleming, L. Burke, Curtis C. Harris, Marek Rusin, H.F. Tazelaar, Peter C. Pairolero, Thomas V. Colby
Publikováno v:
Lung Cancer. 18:140
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.